Ledger.Open graph →
SEC Form D · filed January 19, 2023

EvolveImmune Therapeutics Holding Company, LLC

Offering
$26.0M
Sold
$10.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Branford, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Alessandra Di Bacco · Cambridge, MADirectorStephen Bloch · Branford, CTExec · DirectorIan Taylor · Madison, CTDirectorDerek Yoon · Boston, MADirectorDenis Patrick · New City, NYDirectorJason W. Lettmann · Menlo Park, CADirectorGordon Stebbings · DeForest, WIExec · DirectorSeth Wolkov · Denver, CODirectorAndrew Arsht · WASHINGTON, Washington, D.C.Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗